Skip to content

Feeding Tolerance Evaluation

Feeding Tolerance Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02405572
Enrollment
43
Registered
2015-04-01
Start date
2015-02-28
Completion date
Unknown
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

formula-fed, infants

Brief summary

Crossover study of 2 infant formulas

Detailed description

Exclusively formula-fed infants will participate in two 2-week feeding periods of 2 infant formulas. Daily tolerance records will be kept by caregivers.

Interventions

OTHERinfant formula

infant formulas

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Months
Healthy volunteers
Yes

Inclusion criteria

* Healthy newborn infant * Full-term (\> 37 weeks gestation) * 0-2 months (birth-56 days) of age on enrollment * Infant exclusively formula-fed for at least 2 days prior to enrollment * Having obtained his/her legal representative's informed consent

Exclusion criteria

* Known or suspected cow-milk allergy * Congenital illness or malformation * Significant prenatal and/or postnatal disease * Currently participating in another clinical study

Design outcomes

Primary

MeasureTime frameDescription
stool consistency2 weekscaregivers will document on diary records

Secondary

MeasureTime frameDescription
formula intake2 weekscaregivers will document on diary records
adverse events2 weeksassessed throughout the study
spit-up pattern2 weekscaregivers will document on diary records
mood2 weekscaregivers will document on diary records
sleep pattern2 weekscaregivers will document on diary records
stool pattern2 weekscaregivers will document on diary records

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026